1. Unit startpage
  2. Employees
  3. Roy M. Bremnes
Bilde av Bremnes, Roy M.
Bilde av Bremnes, Roy M.
Department of Clinical Medicine rbr001@post.uit.no +4777645423 Tromsø MH-bygget

Roy M. Bremnes

  • Ragnhild Hellesnes, Tor Åge Myklebust, Sophie Dorothea Fosså, Roy M. Bremnes, Åsa Karlsdottir, Øivind Kvammen et al.:
    Testicular cancer in the cisplatin era: Causes of death and mortality rates in a population-based cohort
    Journal of Clinical Oncology 13. August 2021 ARKIV / DOI
  • Maria Jenvin Støen, Sigve Andersen, Mehrdad Rakaee, Mona Irene Pedersen, Lise Martine Ingebriktsen, Roy M. Bremnes et al.:
    High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
    Scientific Reports 2021 ARKIV / DOI
  • Ragnhild Hellesnes, Tor Åge Myklebust, Roy M. Bremnes, Åsa Karlsdottir, Øivind Kvammen, Helene Francisca Stigter Negaard et al.:
    Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
    Journal of Clinical Oncology 2021 FULLTEKST / ARKIV / DOI
  • Hallgeir Selven, Lill-Tove Rasmussen Busund, Sigve Andersen, Roy M. Bremnes, Thomas Karsten Kilvær :
    High expression of microRNA‑126 relates to favorable prognosis for colon cancer patients
    Scientific Reports 2021 ARKIV / DOI
  • Mehrdad Rakaee, Thomas Karsten Kilvær, Simin Jamaly, Thomas Berg, Erna-Elise Paulsen, Marte Berglund et al.:
    Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
    British Journal of Cancer 2021 DOI
  • Thomas Karsten Kilvær, Erna-Elise Paulsen, Sigve Andersen, Mehrdad Rakaee, Roy M. Bremnes, Lill-Tove Rasmussen Busund et al.:
    Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
    Carcinogenesis 2020 ARKIV / DOI
  • Mehrdad Rakaee, Lill-Tove Busund, Simin Jamaly, Erna-Elise Paulsen, Elin Richardsen, Sigve Andersen et al.:
    Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
    Neoplasia 12. February 2019 ARKIV / DOI
  • Elin Richardsen, Sigve Andersen, Samer Al-Saad, Mehrdad Rakaee, Yngve Nordby, Mona Irene Pedersen et al.:
    Low expression of miR-424-3p is highly correlated with clinical failure in prostate cancer
    Scientific Reports 2019 ARKIV / DOI
  • Elin Richardsen, Sigve Andersen, Christian Melbø-Jørgensen, Mehrdad Rakaee, Nora Ness, Samer Al-Saad et al.:
    MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
    Scientific Reports 2019 ARKIV / DOI
  • Ragnhild Hellesnes, Øivind Kvammen, Tor Åge Myklebust, Roy M. Bremnes, Åsa Karlsdottir, Helene Francisca Stigter Negaard et al.:
    Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
    International Journal of Cancer 2019 FULLTEKST / ARKIV / DOI
  • Christine Damgaard Valan, Jens Erik Slagsvold, Tarje Onsøien Halvorsen, Martin Herje, Roy M. Bremnes, Paal Fr. Brunsvig et al.:
    Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement
    Anticancer Research 2018 ARKIV / DOI
  • Kaja Konstanse Skjefstad, Charles Johannessen, Thea K.W. Grindstad, Thomas Karsten Kilvær, Erna Elise Paulsen, Mona Irene Pedersen et al.:
    A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
    Scientific Reports 2018 ARKIV / DOI
  • Mehrdad Rakaee, Thomas Karsten Kilvær, Stig Manfred Dalen, Elin Richardsen, Erna Elise Paulsen, Sigurd Hald et al.:
    Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
    Human Pathology 2018 DOI
  • Bjørn Henning Grønberg, Bjørg Sjøblom, Tore Wentzel-Larsen, Vickie Elaine Baracos, Marianne Jensen Hjermstad, Nina Kathrine Aass et al.:
    A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer
    European Journal of Clinical Nutrition 2018 ARKIV / DOI
  • Thomas Karsten Kilvær, Mehrdad Rakaee, Turid Hellevik, Arne Östman, Carina Strell, Roy M. Bremnes et al.:
    Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
    PLOS ONE 2018 ARKIV / DOI
  • Line Veronika Hjelle, Per Ole Mobråten Gundersen, Ragnhild Hellesnes, Mette Sprauten, Marianne Brydøy, Torgrim Tanstad et al.:
    Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
    Acta Oncologica 2018 DOI
  • Thea K.W. Grindstad, Elin Richardsen, Sigve Andersen, Kaja Konstanse Skjefstad, Mehrdad Rakaee, Tom Dønnem et al.:
    Progesterone receptors in prostate cancer: Progesterone receptor B is the isoform associated with disease progression
    Scientific Reports 2018 ARKIV / DOI
  • Sigurd Hald, Mehrdad Rakaee, Inigo Zubiavrre Martinez, Elin Richardsen, Samer Al-Saad, Erna Elise Paulsen et al.:
    LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
    Clinical Lung Cancer 2018 DOI
  • Yury Kiselev, Sigve Andersen, Charles Johannessen, Bjørn Fjukstad, Karina Standahl Olsen, Helge Stenvold et al.:
    Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer
    Scientific Reports 2018 ARKIV / DOI
  • Nora Ness, Sigve Andersen, Mehrdad Rakaee, Cecilie Nordbakken, Andrey Yurjevich Valkov, Erna-Elise Paulsen et al.:
    The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort
    OncoTarget 2017 ARKIV / DOI
  • Erna-Elise Paulsen, Thomas Karsten Kilvær, Mehrdad Rakaee, Elin Richardsen, Sigurd Hald, Sigve Andersen et al.:
    CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
    Cancer Immunology and Immunotherapy 2017 ARKIV / DOI
  • Elin Richardsen, Sigve Andersen, Samer Al-Saad, Mehrdad Rakaee, Yngve Nordby, Mona Irene Pedersen et al.:
    Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
    PLOS ONE 2017 ARKIV / DOI
  • Yngve Nordby, Elin Richardsen, Nora Ness, Tom Dønnem, Hitendra R.H. Patel, Lill-Tove Busund et al.:
    High miR-205 expression in normal epithelium is associated with biochemical failure - An argument for epithelial crosstalk in prostate cancer?
    Scientific Reports 2017 ARKIV / DOI
  • Sigve Andersen, Elin Richardsen, Mehrdad Rakaee, Helena Bertilsson, Roy M. Bremnes, Magne Børset et al.:
    Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer
    PLOS ONE 30. November 2017 ARKIV / DOI
  • Åslaug Helland, Odd Terje Brustugun, Sigve Nakken, Ann Rita Halvorsen, Tom Dønnem, Roy M. Bremnes et al.:
    High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival
    International Journal of Cancer 2017 ARKIV / DOI
  • Samer Al-Saad, Elin Richardsen, Thomas Karsten Kilvær, Tom Dønnem, Sigve Andersen, Mehrdad Rakaee et al.:
    The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
    PLOS ONE 2017 ARKIV / DOI
  • Yngve Nordby, Elin Richardsen, Mehrdad Rakaee, Nora Ness, Tom Dønnem, Hitendra R.H. Patel et al.:
    High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence
    Scientific Reports 2017 ARKIV / DOI
  • Asta Bye, Bjørg Sjøblom, Tore Wentzel-Larsen, Bjørn Henning Grønberg, Vickie E. Baracos, Marianne Jensen Hjermstad et al.:
    Muscle mass and association to quality of life in non-small cell lung cancer patients
    Journal of Cachexia, Sarcopenia and Muscle 2017 ARKIV / DOI
  • Erna-Elise Paulsen, Thomas Karsten Kilvær, Mehrdad Rakaee, Samer Al-Saad, Sigurd Hald, Sigve Andersen et al.:
    Assessing PDL-1 and PD-1 in non-small cell lung cancer: a novel immunoscore approach
    Clinical Lung Cancer 2016 ARKIV / DOI
  • Tom Dønnem, Thomas Karsten Kilvær, Sigve Andersen, Elin Richardsen, Erna-Elise Paulsen, Sigurd Hald et al.:
    Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
    Annals of Oncology 2016 DOI
  • Mette Pøhl, Karen Ege Olsen, Rene Holst, Tom Dønnem, Lill-Tove Busund, Roy M. Bremnes et al.:
    Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer
    Acta Oncologica 2016 DOI
  • Bjørn Henning Grønberg, Tarje Onsøien Halvorsen, Øystein Fløtten, Odd Terje Brustugun, Paal Fr. Brunsvig, Ulf Aasebø et al.:
    Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer
    Acta Oncologica 23. October 2015 ARKIV / DOI
  • Line Veronika Hjelle, Roy M. Bremnes, Per Ole Mobråten Gundersen, Mette Sprauten, Marianne Brydøy, Torgrim Tandstad et al.:
    Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors
    Urologic Oncology 2016 DOI
  • Sigve Andersen, Elin Richardsen, Line Moi, Tom Dønnem, Yngve Nordby, Nora Ness et al.:
    Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer – a multicenter (in situ hybridization)study
    Scientific Reports 2016 ARKIV / DOI
  • Øystein Fløtten, Bjørn Henning Grønberg, Stein Harald Sundstrøm, Nina Helbekkmo, Roy M. Bremnes, Christian von Plessen :
    Oral versus intravenous vinorelbine in advanced NSCLC - a retrospective comparison
    Cancer Treatment and Research Communications 2016 DOI
  • Roy M. Bremnes, Lill-Tove Busund, Thomas Karsten Kilvær, Sigve Andersen, Elin Richardsen, Erna-Elise Paulsen et al.:
    The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer
    Journal of Thoracic Oncology 2016 DOI
  • Alv A Dahl, Marie Østby-Deglum, Jan Oldenburg, Roy M. Bremnes, Olav Dahl, Olbjørn Klepp et al.:
    Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings
    Journal of cancer survivorship 2016 DOI
  • Kaja Skjefstad, Thea Grindstad, Mehrdad Rakaee, Elin Richardsen, Tom Dønnem, Thomas Karsten Kilvær et al.:
    Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer
    Steroids 2016 DOI
  • Thomas Karsten Kilvær, Erna-Elise Paulsen, Mehrdad Rakaee, Samer Al-Saad, Ramona Johansen Maurseth, Khalid Al-Shibli et al.:
    The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival
    British Journal of Cancer 2016 ARKIV / DOI
  • Marta Usó, Eloísa Jantus-Lewintre, Roy M. Bremnes, Silvia Calabuig, Ana Blasco, Enrique Pastor et al.:
    Analysis of the immune microenvironment in resected non-small cell lung cancer: The prognostic value of different T lymphocyte markers
    OncoTarget 2016 ARKIV / DOI
  • Thea Grindstad, Kaja Skjefstad, Sigve Andersen, Nora Ness, Yngve Nordby, Samer Al-Saad et al.:
    Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome
    Scientific Reports 2016 ARKIV / DOI
  • Mehrdad Rakaee, Lill-Tove Busund, Erna-Elise Paulsen, Elin Richardsen, Samer Al-Saad, Sigve Andersen et al.:
    Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
    OncoTarget 2016 ARKIV / DOI
  • Tarje Onsøien Halvorsen, Martin Herje, Nina Levin, Roy M. Bremnes, Odd Terje Brustugun, Øystein Fløtten et al.:
    Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer
    Lung Cancer 2016 ARKIV / DOI
  • Tarje Onsøien Halvorsen, Stein Harald Sundstrøm, Øystein Fløtten, Odd Terje Brustugun, Paal Fr. Brunsvig, Ulf Aasebø et al.:
    Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer
    Acta Oncologica 2016 ARKIV / DOI
  • Bjørg Sjøblom, Bjørn Henning Grønberg, Tore Wentzel-Larsen, Vickie E. Baracos, Marianne Jensen Hjermstad, Nina Kathrine Aass et al.:
    Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer
    Clinical Nutrition 01. April 2016 DOI
  • Kaja Konstanse Skjefstad, Thea K.W. Grindstad, Mehrdad Rakaee, Elin Richardsen, Tom Dønnem, Thomas Karsten Kilvær et al.:
    Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]
    Steroids 2018 DOI
  • Gustav Lehne, Kirsten Sundby Hall, Roy M. Bremnes, Thoralf Christoffersen, Lars Slørdal :
    Farmakologisk variabilitet og individualisering av kreftbehandling
    2016
  • Stein Harald Sundstrøm, Paal Fr. Brunsvig, Roy M. Bremnes, Bjørn Henning Grønberg, Odd Terje Brustugun :
    Lungekreft
    2016
  • Roy M. Bremnes, Tom Dønnem, Lill-Tove Busund :
    Importance of tumor infiltrating lymphocytes in non-small cell lung cancer?
    Annals of Translational Medicine 2016 DOI
  • Sigurd Hald, Yury Kiselev, Samer Al-Saad, Elin Helmine Richardsen, Charles Walquist Johannessen, Marte Eilertsen et al.:
    Erratum: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. [BMC Cancer. 15, (2015) (441)] DOI: 10.1186/s12885-015-1446-z
    BMC Cancer 2016 DOI

    • The 50 latest publications is shown on this page. See all publications in Cristin here →
    MH-bygget

    Attachments: